{
    "company_name": "CHIMERIC THERAPEUTICS LIMITED",
    "address": "Level 3, 62 Lygon Street, CARLTON SOUTH, VIC, AUSTRALIA, 3053",
    "summary": "Chimeric is a biotechnology company developing a cancer cell therapy drug",
    "details": "Chimeric is a biotechnology company developing a cancer cell therapy drug",
    "website": "http://www.chimerictherapeutics.com/",
    "stock_code": "CHM",
    "links": "['https://chimerictherapeutics.com', 'https://chimerictherapeutics.com/', 'https://chimerictherapeutics.com/#overview-our-missio', 'https://chimerictherapeutics.com/#news-and-events', 'https://chimerictherapeutics.com/#stock-quote', 'https://chimerictherapeutics.com/about-us/', 'https://chimerictherapeutics.com/about-us/#at-a-glance', '#our-values', 'https://chimerictherapeutics.com/about-us/#management-team', 'https://chimerictherapeutics.com/about-us/#board-of-directors', 'https://chimerictherapeutics.com/about-us/#scientific-advisors', 'https://chimerictherapeutics.com/about-us/#scientific-advisors', 'https://chimerictherapeutics.com/about-us/#glioblastoma-scientific', 'https://chimerictherapeutics.com/science/', 'https://chimerictherapeutics.com/science/#nk-cell-derived-allogeneic', 'https://chimerictherapeutics.com/science/#chm-0201', 'https://chimerictherapeutics.com/science/#chm-0301', 'https://chimerictherapeutics.com/science/#chm-1301', 'https://chimerictherapeutics.com/science/#chm-2301', 'https://chimerictherapeutics.com/science/#chm-3301', 'https://chimerictherapeutics.com/science/#chm-1101-cltx', 'https://chimerictherapeutics.com/science/#chm-1101-cltx', 'https://chimerictherapeutics.com/science/#chm-2101-cltx', 'https://chimerictherapeutics.com/science/#collaborations', 'https://chimerictherapeutics.com/science/#about-cell-therapy', 'https://chimerictherapeutics.com/our-pipeline/', 'https://chimerictherapeutics.com/our-pipeline/#our-pipeline', 'https://chimerictherapeutics.com/our-pipeline/#clinical-trials', 'https://chimerictherapeutics.com/our-pipeline/#chm-1101', 'https://chimerictherapeutics.com/our-pipeline/#chm-0201', 'https://chimerictherapeutics.com/our-pipeline/#abstract-and-publications', 'https://chimerictherapeutics.com/news-and-events/', 'https://chimerictherapeutics.com/news-and-events/#press-releases', 'https://chimerictherapeutics.com/news-and-events/#events-and-presentations', 'https://chimerictherapeutics.com/news-and-events/#media-coverage', 'https://chimerictherapeutics.com/news-and-events/#media-resources', 'https://investorhub.chimerictherapeutics.com', 'https://chimerictherapeutics.com/careers/', 'https://chimerictherapeutics.com/', 'https://chimerictherapeutics.com/#overview-our-missio', 'https://chimerictherapeutics.com/#news-and-events', 'https://chimerictherapeutics.com/#stock-quote', 'https://chimerictherapeutics.com/about-us/', 'https://chimerictherapeutics.com/about-us/#at-a-glance', '#our-values', 'https://chimerictherapeutics.com/about-us/#management-team', 'https://chimerictherapeutics.com/about-us/#board-of-directors', 'https://chimerictherapeutics.com/about-us/#scientific-advisors', 'https://chimerictherapeutics.com/about-us/#scientific-advisors', 'https://chimerictherapeutics.com/about-us/#glioblastoma-scientific', 'https://chimerictherapeutics.com/science/', 'https://chimerictherapeutics.com/science/#nk-cell-derived-allogeneic', 'https://chimerictherapeutics.com/science/#chm-0201', 'https://chimerictherapeutics.com/science/#chm-0301', 'https://chimerictherapeutics.com/science/#chm-1301', 'https://chimerictherapeutics.com/science/#chm-2301', 'https://chimerictherapeutics.com/science/#chm-3301', 'https://chimerictherapeutics.com/science/#chm-1101-cltx', 'https://chimerictherapeutics.com/science/#chm-1101-cltx', 'https://chimerictherapeutics.com/science/#chm-2101-cltx', 'https://chimerictherapeutics.com/science/#collaborations', 'https://chimerictherapeutics.com/science/#about-cell-therapy', 'https://chimerictherapeutics.com/our-pipeline/', 'https://chimerictherapeutics.com/our-pipeline/#our-pipeline', 'https://chimerictherapeutics.com/our-pipeline/#clinical-trials', 'https://chimerictherapeutics.com/our-pipeline/#chm-1101', 'https://chimerictherapeutics.com/our-pipeline/#chm-0201', 'https://chimerictherapeutics.com/our-pipeline/#abstract-and-publications', 'https://chimerictherapeutics.com/news-and-events/', 'https://chimerictherapeutics.com/news-and-events/#press-releases', 'https://chimerictherapeutics.com/news-and-events/#events-and-presentations', 'https://chimerictherapeutics.com/news-and-events/#media-coverage', 'https://chimerictherapeutics.com/news-and-events/#media-resources', 'https://investorhub.chimerictherapeutics.com', 'https://chimerictherapeutics.com/careers/', 'https://www.linkedin.com/company/chimeric-therapeutics/', 'https://www.youtube.com/channel/UCjQLccp8y2A4BmxMVCT06_g', 'https://twitter.com/Chimeric', 'https://chimerictherapeutics.com/contact/', 'https://chimerictherapeutics.com/wp-content/uploads/2021/11/Chimeric-transforms-portfolio-with-a-clinically-validated-off-the-shelf-natural-killer-nk-cell-platform.pdf', 'https://chimerictherapeutics.com/science/', 'https://chimerictherapeutics.com/science/', 'https://chimerictherapeutics.com/science/', 'https://chimerictherapeutics.com/our-pipeline/', 'https://chimerictherapeutics.com/our-pipeline/', 'https://chimerictherapeutics.com/our-pipeline/', 'https://chimerictherapeutics.com/about-us/', 'https://chimerictherapeutics.com/about-us/', 'https://chimerictherapeutics.com/about-us/', 'https://chimerictherapeutics.com/wp-content/uploads/2023/10/CHM2101IND-103023.pdf', 'https://chimerictherapeutics.com/wp-content/uploads/2023/10/CHM2101IND-103023.pdf', 'https://chimerictherapeutics.com/wp-content/uploads/2023/10/ASX-Announcement-23Oct2023-2627696.pdf', 'https://chimerictherapeutics.com/wp-content/uploads/2023/10/ASX-Announcement-23Oct2023-2627696.pdf', 'https://chimerictherapeutics.com/wp-content/uploads/2023/06/Launch-of-New-Phase-1B-Glioblastoma-Clinical-Trial-5-Jun-2023.pdf', 'https://chimerictherapeutics.com/wp-content/uploads/2023/06/Launch-of-New-Phase-1B-Glioblastoma-Clinical-Trial-5-Jun-2023.pdf', 'https://chimerictherapeutics.com/wp-content/uploads/2023/06/AGM-EGM-Lumi-Virtual-User-Meeting-Guide-2023-Zoom-or-Teams-Meeting-FYI-356918564_1.pdf', 'https://chimerictherapeutics.com/wp-content/uploads/2023/06/AGM-EGM-Lumi-Virtual-User-Meeting-Guide-2023-Zoom-or-Teams-Meeting-FYI-356918564_1.pdf', 'https://chimerictherapeutics.com/wp-content/uploads/2023/06/Notice-of-EGM-29-June-2023.pdf', 'https://chimerictherapeutics.com/wp-content/uploads/2023/06/Notice-of-EGM-29-June-2023.pdf', 'https://chimerictherapeutics.com/wp-content/uploads/2023/04/New-CLTX-CAR-technology-patent-protection-in-India-Israel-28-Apr-2023-02659568.pdf', 'https://chimerictherapeutics.com/wp-content/uploads/2023/04/New-CLTX-CAR-technology-patent-protection-in-India-Israel-28-Apr-2023-02659568.pdf', '', '', 'https://www.linkedin.com/company/chimeric-therapeutics/', 'https://www.youtube.com/channel/UCjQLccp8y2A4BmxMVCT06_g', 'https://twitter.com/Chimeric', 'https://chimerictherapeutics.com/contact/']",
    "images": "https://chimerictherapeutics.com/wp-content/uploads/2021/08/CHM-Logo-Hex.png, https://chimerictherapeutics.com/wp-content/uploads/2021/08/Chimeric-Therapeutics-white.svg, https://chimerictherapeutics.com/wp-content/uploads/2021/08/icon-arrow.png, https://chimerictherapeutics.com/wp-content/uploads/2021/08/icon-arrow.png",
    "company_logo_link": "https://chimerictherapeutics.com/wp-content/uploads/2021/08/CHM-Logo-Hex.png"
}